Crossref
Key Vectors of Innovation in Cancer Drug Therapy for Clinical Practice
Practical oncology · 30.03.2026 · v. 27 (1) · 39-51
DOI: 10.31917/2701039 ↗Kurz gefasst
Fachartikel in der Zeitschrift Practical oncology, online erschienen am 30.03.2026. Verfasst von M.A. Krasavina.
Abstract (Originalsprache)
immune checkpoint inhibitors, antibody-drug conjugates, targeted therapy, circulating tumor DNA, precision medicine, artificial intelligence in oncology.
Zitieren
APA
Krasavina, M. (2026). Key Vectors of Innovation in Cancer Drug Therapy for Clinical Practice. Practical oncology, v. 27(1), 39-51. https://doi.org/10.31917/2701039
Vancouver
Krasavina M. Key Vectors of Innovation in Cancer Drug Therapy for Clinical Practice. Practical oncology. 2026;v. 27(1):39-51. doi:10.31917/2701039
BibTeX
@article{Krasavina2026,
author = {Krasavina, M.A.},
title = {Key Vectors of Innovation in Cancer Drug Therapy for Clinical Practice},
journal = {Practical oncology},
year = {2026},
volume = {v. 27},
number = {1},
pages = {39--51},
doi = {10.31917/2701039}
}
EUVIMED